Vasoactive intestinal peptide represses activation of tumor-associated macrophages in gastric cancer via regulation of TNFα, IL-6, IL-12 and iNOS
Authors:
- 19 August 2015
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 47 (4) , 1361-1370
Abstract
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publicationsKeywords
This publication has 37 references indexed in Scilit:
- Tumor-Associated Macrophages: From Mechanisms to TherapyImmunity, 2014
- Vasoactive intestinal peptide increases VEGF expression to promote proliferation of brain vascular endothelial cells via the cAMP/PKA pathway after ischemic insult in vitroPeptides, 2013
- Macrophage Regulation of Tumor Responses to Anticancer TherapiesCancer Cell, 2013
- Current questions for the treatment of advanced gastric cancerCancer Treatment Reviews, 2013
- Vasoactive intestinal peptide induces oxidative stress and suppresses metastatic potential in human clear cell renal cell carcinomaMolecular and Cellular Endocrinology, 2013
- Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functionsAmino Acids, 2011
- Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnosticsExpert Review of Molecular Diagnostics, 2011
- An amino-bisphosphonate targets MMP-9–expressing macrophages and angiogenesis to impair cervical carcinogenesisJournal of Clinical Investigation, 2004
- The epidemiology of gastric cancerGastric Cancer, 2002
- The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapiesThe Journal of Pathology, 2002